600976 Stock Overview
Manufactures and sells medicines in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Jianmin Pharmaceutical Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥42.50 |
| 52 Week High | CN¥72.30 |
| 52 Week Low | CN¥39.82 |
| Beta | 0.72 |
| 11 Month Change | -4.13% |
| 3 Month Change | 0.73% |
| 1 Year Change | -38.06% |
| 33 Year Change | -18.14% |
| 5 Year Change | 153.13% |
| Change since IPO | 41.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600976 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.9% | -0.6% | -2.8% |
| 1Y | -38.1% | -8.7% | 2.0% |
Return vs Industry: 600976 underperformed the CN Pharmaceuticals industry which returned -7.9% over the past year.
Return vs Market: 600976 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 600976 volatility | |
|---|---|
| 600976 Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600976 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600976's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2,497 | Jun Wang | www.whjm.com |
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It offers medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name.
Jianmin Pharmaceutical Group Co.,Ltd. Fundamentals Summary
| 600976 fundamental statistics | |
|---|---|
| Market cap | CN¥6.52b |
| Earnings (TTM) | CN¥427.95m |
| Revenue (TTM) | CN¥3.98b |
15.2x
P/E Ratio1.6x
P/S RatioIs 600976 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600976 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.98b |
| Cost of Revenue | CN¥2.28b |
| Gross Profit | CN¥1.70b |
| Other Expenses | CN¥1.27b |
| Earnings | CN¥427.95m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.79 |
| Gross Margin | 42.78% |
| Net Profit Margin | 10.76% |
| Debt/Equity Ratio | 6.3% |
How did 600976 perform over the long term?
See historical performance and comparison